ISR’s Report Analyzes Investigator Payments across 11 Therapeutic Areas

Informing the pharmaceutical and biotech industry. Cary, N.C. – October 30, 2012 – Industry Standard Research (ISR) today announced the availability of their newest report, “Benchmarking Investigator Payments,” which analyzes the level of compensation investigative sites receive for participation in clinical studies. “Investigator payments can account for over 40% of total trial costs, so it … Continued

ISR’s Hepatitis C Market Analysis Shows a Deep Pipeline, Uncovers Lack of Internet Search Visibility for Current Therapies

Informing the pharmaceutical and biotech industry. Cary, N.C. – October 9, 2012 – Industry Standard Research (ISR) today announced the availability of their latest report, “Hepatitis C: Social Media, Search, and Market Analysis,” providing a product and pipeline analysis of the Hepatitis C market, as well as a never before seen in-depth social media and … Continued

ISR Reports: Sponsors Indicate a Shift Towards Central Labs in Emerging Markets, Asia

Informing the pharmaceutical and biotech industry. Cary, N.C. – October  2, 2012 – Industry Standard Research (ISR) today announced the availability of their newest clinical development trends report, “Central Lab Market Dynamics and Outsourcing Performance,” which provides an in-depth analysis of topics and trends having an impact on the market for central lab market in … Continued

ISR CUSTOMERS